Validea James P. O'Shaughnessy Strategy Daily Upgrade Report

Validea's Growth/Value Investor model, leveraging James P. O'Shaughnessy's quantitative strategy, has upgraded Eastman Chemical Co (EMN) and HSBC Holdings PLC (ADR) (HSBC) to a 100% rating. EMN, a mid-cap chemical manufacturer, saw its rating increase from 75%, while large-cap bank HSBC's rating rose from 80%, with both upgrades driven by strong underlying fundamentals and valuation. A 100% score indicates strong interest from this back-tested strategy, signaling these companies as noteworthy opportunities for investors following quantitative models.

Analysis

Eastman Chemical (EMN) and HSBC Holdings (HSBC) have received significant upgrades to a 100% rating from Validea's model, which is based on James P. O'Shaughnessy's quantitative investment strategy. A 100% score from this model indicates strong interest based on historically back-tested criteria. For Eastman Chemical, a mid-cap value stock, the upgrade from 75% was driven by its success in passing screens for Market Cap, Earnings Per Share Persistence, Price/Sales Ratio, and Relative Strength, suggesting a profile of consistent profitability, positive market momentum, and a reasonable valuation. For HSBC, a large-cap value bank, the upgrade from 80% reflects its strong performance on key value metrics including Cash Flow Per Share, a stable share count, strong trailing sales, and its dividend payout. The distinct criteria passed by each firm highlight the specific fundamental and valuation strengths that the quantitative model has identified, positioning both as noteworthy under the O'Shaughnessy framework.

Key Decisions for Investors

• Investors following quantitative strategies should consider the 100% score for both EMN and HSBC as a strong signal to evaluate initiating or adding to positions, as this rating indicates alignment with a historically successful factor-based model.
• For value and income-focused portfolios, HSBC's strong performance on cash flow, sales, and dividend metrics makes it a compelling candidate for further due diligence as a core large-cap financial holding.
• Eastman Chemical's successful screening on both value (Price/Sales) and growth/momentum (EPS Persistence, Relative Strength) factors may appeal to 'Growth at a Reasonable Price' (GARP) investors.
• While the quantitative signals are positive, these should be used as a screening tool, and investors should still assess the specific macroeconomic factors currently impacting the global chemical manufacturing and banking industries.